Search - tctmd.com

Displaying 41 - 60 of 204

Sort: Relevancy | Date

Presentation TCT 2019

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

Presenter: IN-HO CHAE

September 29, 2019

Presentation TCT 2019

ORSIRO: An “Ultra-Thin Strut” Metallic DES With Bioresorbable Polymer

Presenter: George Dangas

September 28, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

Presenter: Azfar Zaman

September 25, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Industry News

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

May 23, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

Podcast TCTMD Talking Points

TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population

May 15, 2019

Presentation JIM 2019

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Presenter: Giuseppe Tarantini

February 14, 2019

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

Presentation TCT Abstracts Posters 2018

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

Presenter: Krzysztof Milewski

September 25, 2018

Presentation TCT 2018

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Fernando Alfonso, Juan F. Granada, David E. Kandzari

September 23, 2018

Presentation TCT 2018

RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold

Presenter: Michael Haude, Robert-Jan van Geuns, Antonio Colombo

September 23, 2018

Advertisement

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

ORSIRO: An “Ultra-Thin Strut” Metallic DES With Bioresorbable Polymer

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

TCTMD’s Top 10 Most Popular Stories for May 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

TCTMD’s Top 10 Most Popular Stories for September 2018

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content